CVRX PEER ANALYSIS

CVRx Inc — metric-by-metric comparison with peers and the industry median

CVRXCVRx Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value itDuel

Overall Profile & Returns

· Medical Devices

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
CVRXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
CVRX-13.3%ONCSM+203.3%SN+4.2%MEDTR-8.2%ANGEN+2.7%4DX+1,670.8%
Year-to-Date (YTD)
CVRX-21.1%ONCSM-4.8%SN-7.6%MEDTR+0.3%ANGEN-3.0%4DX+8.1%

Key Metric Comparison

P/E

Lower is better
CVRXONCSM122.41SN20.56MEDTR596.83ANGEN4DXMedian 27.44

ROE

Higher is better
CVRX-107.0%ONCSM12.9%SN12.1%MEDTR0.2%ANGEN-21.0%4DXMedian -8.6%

Net Margin

Higher is better
CVRX-89.1%ONCSM6.3%SN10.1%MEDTR0.2%ANGEN-45.0%4DX-3,684.6%Median -5.7%

Revenue Growth

Higher is better
CVRX11.7%ONCSM39.1%SNMEDTR6.5%ANGEN11.7%4DX-26.0%Median 7.4%

All Metrics

Valuation
MetricCVRXONCSMSNMEDTRANGEN4DXInd. Median
P/E122.4120.56596.8327.44
P/B5.0713.362.481.081.32-74.162.48
EV/EBITDA25.469.8810.9334.7715.23
P/S2.507.662.091.182.95243.162.66
Financial Health
MetricCVRXONCSMSNMEDTRANGEN4DXInd. Median
Current Ratio10.202.252.573.582.316.573.28
Debt/Equity204.0%35.0%62.9%1.0%28.1%-22.6%44.7%
NetDebt/EBITDA0.280.421.72-1.644.710.710.82
Profitability
MetricCVRXONCSMSNMEDTRANGEN4DXInd. Median
Net Margin-89.1%6.3%10.1%0.2%-45.0%-3,684.6%-5.7%
ROE-107.0%12.9%12.1%0.2%-21.0%-8.6%
ROA-45.9%8.0%6.1%0.2%-15.7%-264.3%-6.4%
EBITDA Margin-77.8%30.6%25.6%9.4%9.8%-818.8%5.2%
Growth + Dividend
MetricCVRXONCSMSNMEDTRANGEN4DXInd. Median
Rev. Growth11.7%39.1%6.5%11.7%-26.0%7.4%
NI Growth-62.9%16.7%
Div. Yield0.0%3.5%1.1%0.0%1.1%
Payout0.0%52.8%656.3%0.0%39.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CVRX

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.